MELPHALAN THERAPY IN MYELOMATOSIS.
作者信息
WALDENSTROEM J
出版信息
Br Med J. 1964 Apr 4;1(5387):859-65. doi: 10.1136/bmj.1.5387.859.
Abstract
摘要
相似文献
1
MELPHALAN THERAPY IN MYELOMATOSIS.美法仑治疗骨髓瘤
Br Med J. 1964 Apr 4;1(5387):859-65. doi: 10.1136/bmj.1.5387.859.
2
URETHANE GEL REACTION IN DIAGNOSIS OF MULTIPLE MYELOMA AND MACROGLOBULINEMIA.用于诊断多发性骨髓瘤和巨球蛋白血症的氨基甲酸乙酯凝胶反应
Am J Clin Pathol. 1965 Feb;43:157-60. doi: 10.1093/ajcp/43.2.157.
3
[M-COMPONENTS IN SERUM. A 4-YEAR MATERIAL FROM A COUNTY GENERAL HOSPITAL].
Nord Med. 1964 Dec 17;72:1501-4.
4
[URETHANE GEL REACTION IN THE DIAGNOSIS OF KAHLER'S DISEASE].[用于卡勒氏病诊断的氨基甲酸乙酯凝胶反应]
Arq Patol. 1964 Dec;36:95-7.
5
Macroglobulinemia and myelomatosis.巨球蛋白血症和骨髓瘤
Acta Med Scand. 1960 Dec 20;168:431-7. doi: 10.1111/j.0954-6820.1960.tb06674.x.
6
MYELOMATOSIS. A CLINICAL AND BIOCHEMICAL STUDY OF 105 CASES.
Acta Med Scand. 1964 Oct;176:509-24.
7
THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.骨髓瘤及相关病症中γ球蛋白的代谢
J Clin Invest. 1963 Dec;42(12):1858-68. doi: 10.1172/JCI104870.
8
9
[WALDENSTROEM'S MACROGLOBULINEMIA].[华氏巨球蛋白血症]
Belg Tijdschr Geneesk. 1964 Jun 15;20:634-9.
10
Blood volume and hematocrit value in macroglobulinemia and myeloma.巨球蛋白血症和骨髓瘤中的血容量及血细胞比容值
Arch Intern Med. 1969 Apr;123(4):394-6.
引用本文的文献
1
Update on second primary malignancies in multiple myeloma: a focused review.多发性骨髓瘤中第二原发恶性肿瘤的研究进展：重点综述。
Leukemia. 2014 Jul;28(7):1423-6. doi: 10.1038/leu.2014.22. Epub 2014 Jan 14.
2
MELPHALAN IN THE TREATMENT OF MYELOMATOSIS.美法仑治疗骨髓瘤
Br Med J. 1964 Jun 27;1(5399):1664-9. doi: 10.1136/bmj.1.5399.1664.
3
Peptichemio induction therapy in myelomatosis.
Cancer Chemother Pharmacol. 1982;8(1):9-16. doi: 10.1007/BF00292864.
4
Multiple myeloma. Clinical correlation of immunoglobulin changes with therapy. A report of 23 cases.多发性骨髓瘤。免疫球蛋白变化与治疗的临床相关性。23例报告。
Calif Med. 1969 Jan;110(1):1-10.
5
The management of myelomatosis.骨髓瘤的治疗
Postgrad Med J. 1968 Oct;44(516):803-6. doi: 10.1136/pgmj.44.516.803.
6
[Plasmocytoma as a neurosurgical clinical picture].[浆细胞瘤作为一种神经外科临床病症]
Acta Neurochir (Wien). 1970 Apr 21;22(1):91-108. doi: 10.1007/BF01406772.
7
Pulmonary fibrosis following therapy with Melphalan for multiple myeloma.美法仑治疗多发性骨髓瘤后发生的肺纤维化。
J Clin Pathol. 1972 Aug;25(8):668-73. doi: 10.1136/jcp.25.8.668.
8
The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma.1-苯丙氨酸氮芥对多发性骨髓瘤中抗球蛋白抗体的影响。
Clin Exp Immunol. 1971 Jan;8(1):91-100.
9
Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy.多发性骨髓瘤：在看似化疗成功的过程中发生浆细胞肉瘤。
J Clin Pathol. 1973 Sep;26(9):649-59. doi: 10.1136/jcp.26.9.649.
10
Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.抗肿瘤和免疫抑制药物。I. 生化及临床药理学考量
Drugs. 1972;3(3):227-53. doi: 10.2165/00003495-197203030-00004.
本文引用的文献
1
Multiple plasmocytoma treated with urethane.用氨基甲酸乙酯治疗多发性浆细胞瘤。
Acta Med Scand. 1950;136(5):388-92. doi: 10.1111/j.0954-6820.1950.tb09653.x.
2
Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period.用乌拉坦治疗多发性骨髓瘤；2年半期间66例的经验。
J Am Med Assoc. 1951 Oct 27;147(9):824-7. doi: 10.1001/jama.1951.03670260026008.
3
Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.多发性骨髓瘤。III. 氨基甲酸乙酯疗法对浆细胞生长、异常血清蛋白成分及本斯·琼斯蛋白尿的影响。
J Clin Invest. 1950 Sep;29(9):1243-60. doi: 10.1172/JCI102362.
4
Attempt at treatment of 21 patients with myeloma or macroglobulinemia with p-di-2-chlorethylamino-1-phenylalanine (melphalan).尝试用对二（2-氯乙基）氨基-1-苯丙氨酸（美法仑）治疗21例骨髓瘤或巨球蛋白血症患者。
Nouv Rev Fr Hematol. 1962 Jul-Aug;2:611-6.
5
6
[Clinical experiences with sarcolysin in neoplastic diseases].
Ann N Y Acad Sci. 1958 Apr 24;68(3):1128-32. doi: 10.1111/j.1749-6632.1958.tb42675.x.
7
Case of multiple myeloma complicated by agranulocytosis.多发性骨髓瘤合并粒细胞缺乏症病例。
Br Med J. 1956 Jan 7;1(4957):27-8. doi: 10.1136/bmj.1.4957.27.
Zotero 插件